37564004|t|Inhibition of the interaction between microglial adenosine 2A receptor and NLRP3 inflammasome attenuates neuroinflammation posttraumatic brain injury.
37564004|a|AIMS: Adenosine 2A receptor (A2A R) is widely expressed in the brain and plays important roles in neuroinflammation, and the nucleotide-binding oligomerization domain, leucine-rich repeat, and pyrin domain-containing protein 3 (NLRP3) inflammasome is a crucial component of the innate immune system while the regulation of A2A R on it in the central nervous system (CNS) has not been clarified. METHODS: The effects of microglial A2A R on NLRP3 inflammasome assembly and activation were investigated in wild-type, A2A R- or NLRP3-knockout primary microglia with pharmacological treatment. Microglial A2A R or NLRP3 conditional knockout mice were used to interrogate the effects of this regulation on neuroinflammation posttraumatic brain injury (TBI). RESULTS: We found that A2A R directly interacted with NLRP3 and facilitated NLRP3 inflammasome assembly and activation in primary microglia while having no effects on mRNA levels of inflammasome components. Inhibition of the interaction via A2A R agonist or knockout attenuated inflammasome assembly and activation in vitro. In the TBI model, microglial A2A R and NLRP3 were co-expressed at high levels in microglia next to the peri-injured cortex, and abrogating of this interaction by microglial NLRP3 or A2A R conditional knockout attenuated the neurological deficits and neuropathology post-TBI via reducing the NLRP3 inflammasome activation. CONCLUSION: Our results demonstrated that inhibition of the interaction between A2A R and NLRP3 in microglia could mitigate the NLRP3 inflammasome assembly and activation and ameliorate the neuroinflammation post-TBI. It provides new insights into the effects of A2A R on neuroinflammation regulation post-TBI and offers a potential target for the treatment of NLRP3 inflammasome-related CNS diseases.
37564004	61	70	 receptor	Gene	11540
37564004	49	61	adenosine 2A	DNAMutation	tmVar:c|Allele|A|ADENOSINE2;VariantGroup:1;OriginalGene:216799;CorrespondingGene:114548;CorrespondingSpecies:10090
37564004	75	80	NLRP3	Gene	216799
37564004	105	122	neuroinflammation	Disease	MESH:D000090862
37564004	123	149	posttraumatic brain injury	Disease	MESH:D001930
37564004	169	178	 receptor	Gene	11540
37564004	157	169	Adenosine 2A	DNAMutation	tmVar:c|SUB|A|DENOSINE2|A;HGVS:c.DENOSINE2A>A;VariantGroup:2;OriginalGene:11540;CorrespondingGene:135;CorrespondingSpecies:10090
37564004	183	185	 R	Gene	11540
37564004	180	183	A2A	DNAMutation	tmVar:c|SUB|A|2|A;HGVS:c.2A>A;VariantGroup:0;OriginalGene:11540;CorrespondingGene:135;CorrespondingSpecies:10090
37564004	249	266	neuroinflammation	Disease	MESH:D000090862
37564004	319	377	leucine-rich repeat, and pyrin domain-containing protein 3	Gene	102641031
37564004	379	384	NLRP3	Gene	216799
37564004	477	479	 R	Gene	11540
37564004	474	477	A2A	DNAMutation	tmVar:c|SUB|A|2|A;HGVS:c.2A>A;VariantGroup:0;OriginalGene:11540;CorrespondingGene:135;CorrespondingSpecies:10090
37564004	581	584	A2A	DNAMutation	tmVar:c|SUB|A|2|A;HGVS:c.2A>A;VariantGroup:0;OriginalGene:11540;CorrespondingGene:135;CorrespondingSpecies:10090
37564004	584	586	 R	Gene	11540
37564004	590	595	NLRP3	Gene	216799
37564004	668	670	 R	Gene	11540
37564004	665	668	A2A	DNAMutation	tmVar:c|SUB|A|2|A;HGVS:c.2A>A;VariantGroup:0;OriginalGene:11540;CorrespondingGene:135;CorrespondingSpecies:10090
37564004	675	680	NLRP3	Gene	216799
37564004	754	756	 R	Gene	11540
37564004	751	754	A2A	DNAMutation	tmVar:c|SUB|A|2|A;HGVS:c.2A>A;VariantGroup:0;OriginalGene:11540;CorrespondingGene:135;CorrespondingSpecies:10090
37564004	760	765	NLRP3	Gene	216799
37564004	851	868	neuroinflammation	Disease	MESH:D000090862
37564004	869	895	posttraumatic brain injury	Disease	MESH:D001930
37564004	897	900	TBI	Disease	MESH:D000070642
37564004	929	931	 R	Gene	11540
37564004	926	929	A2A	DNAMutation	tmVar:c|SUB|A|2|A;HGVS:c.2A>A;VariantGroup:0;OriginalGene:11540;CorrespondingGene:135;CorrespondingSpecies:10090
37564004	957	962	NLRP3	Gene	216799
37564004	979	984	NLRP3	Gene	216799
37564004	1147	1149	 R	Gene	11540
37564004	1144	1147	A2A	DNAMutation	tmVar:c|SUB|A|2|A;HGVS:c.2A>A;VariantGroup:0;OriginalGene:11540;CorrespondingGene:135;CorrespondingSpecies:10090
37564004	1235	1238	TBI	Disease	MESH:D000070642
37564004	1257	1260	A2A	DNAMutation	tmVar:c|SUB|A|2|A;HGVS:c.2A>A;VariantGroup:0;OriginalGene:11540;CorrespondingGene:135;CorrespondingSpecies:10090
37564004	1260	1262	 R	Gene	11540
37564004	1267	1272	NLRP3	Gene	216799
37564004	1401	1406	NLRP3	Gene	216799
37564004	1410	1413	A2A	DNAMutation	tmVar:c|SUB|A|2|A;HGVS:c.2A>A;VariantGroup:0;OriginalGene:11540;CorrespondingGene:135;CorrespondingSpecies:10090
37564004	1413	1415	 R	Gene	11540
37564004	1452	1473	neurological deficits	Disease	MESH:D009461
37564004	1498	1501	TBI	Disease	MESH:D000070642
37564004	1519	1524	NLRP3	Gene	216799
37564004	1630	1633	A2A	DNAMutation	tmVar:c|SUB|A|2|A;HGVS:c.2A>A;VariantGroup:0;OriginalGene:11540;CorrespondingGene:135;CorrespondingSpecies:10090
37564004	1633	1635	 R	Gene	11540
37564004	1640	1645	NLRP3	Gene	216799
37564004	1678	1683	NLRP3	Gene	216799
37564004	1740	1757	neuroinflammation	Disease	MESH:D000090862
37564004	1763	1766	TBI	Disease	MESH:D000070642
37564004	1816	1818	 R	Gene	11540
37564004	1813	1816	A2A	DNAMutation	tmVar:c|SUB|A|2|A;HGVS:c.2A>A;VariantGroup:0;OriginalGene:11540;CorrespondingGene:135;CorrespondingSpecies:10090
37564004	1822	1839	neuroinflammation	Disease	MESH:D000090862
37564004	1856	1859	TBI	Disease	MESH:D000070642
37564004	1911	1916	NLRP3	Gene	216799
37564004	1938	1950	CNS diseases	Disease	MESH:D002493
37564004	Association	216799	HGVS:c.2A>A;CorrespondingGene:135
37564004	Association	MESH:D001930	216799
37564004	Association	MESH:D001930	CorrespondingGene:114548;CorrespondingSpecies:10090;OriginalGene:216799;VariantGroup:1;tmVar:c
37564004	Association	MESH:D000090862	HGVS:c.DENOSINE2A>A;CorrespondingGene:135
37564004	Association	216799	HGVS:c.DENOSINE2A>A;CorrespondingGene:135
37564004	Bind	11540	HGVS:c.DENOSINE2A>A;CorrespondingGene:135
37564004	Association	MESH:D000090862	CorrespondingGene:114548;CorrespondingSpecies:10090;OriginalGene:216799;VariantGroup:1;tmVar:c
37564004	Bind	11540	HGVS:c.2A>A;CorrespondingGene:135
37564004	Association	MESH:D001930	11540
37564004	Association	MESH:D002493	216799
37564004	Association	MESH:D002493	CorrespondingGene:114548;CorrespondingSpecies:10090;OriginalGene:216799;VariantGroup:1;tmVar:c
37564004	Association	MESH:D002493	HGVS:c.DENOSINE2A>A;CorrespondingGene:135
37564004	Association	MESH:D009461	11540
37564004	Association	MESH:D000090862	HGVS:c.2A>A;CorrespondingGene:135
37564004	Association	MESH:D009461	CorrespondingGene:114548;CorrespondingSpecies:10090;OriginalGene:216799;VariantGroup:1;tmVar:c
37564004	Association	MESH:D002493	HGVS:c.2A>A;CorrespondingGene:135
37564004	Association	MESH:D000090862	11540
37564004	Association	MESH:D009461	HGVS:c.DENOSINE2A>A;CorrespondingGene:135
37564004	Association	MESH:D009461	216799
37564004	Association	11540	216799
37564004	Association	MESH:D000070642	HGVS:c.2A>A;CorrespondingGene:135
37564004	Association	MESH:D009461	HGVS:c.2A>A;CorrespondingGene:135
37564004	Association	MESH:D000070642	CorrespondingGene:114548;CorrespondingSpecies:10090;OriginalGene:216799;VariantGroup:1;tmVar:c
37564004	Association	MESH:D000070642	HGVS:c.DENOSINE2A>A;CorrespondingGene:135
37564004	Association	MESH:D000090862	216799
37564004	Association	102641031	HGVS:c.DENOSINE2A>A;CorrespondingGene:135
37564004	Association	MESH:D002493	11540
37564004	Association	MESH:D000070642	216799
37564004	Association	MESH:D001930	114548
37564004	Association	MESH:D000090862	135
37564004	Association	MESH:D000090862	114548
37564004	Association	MESH:D002493	114548
37564004	Association	MESH:D002493	135
37564004	Association	MESH:D009461	114548
37564004	Association	MESH:D009461	135
37564004	Association	MESH:D000070642	135
37564004	Association	MESH:D000070642	114548

